You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Microfluidic selection of monoclonal antibodies

    SBC: AFFOMIX, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Nearly 20 years ago, partially as a response to leveraging the genomics research the NIH invested in the development of gene array technologies. These gene chips' enabled great breakthroughs in our understanding of the underlying biological processes that occur in cells and tissues. These increased understandings have already led to new therapies that affect ...

    SBIR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health
  2. Emulsion phage display for high-throughput isolation of affinity binders

    SBC: AFFOMIX, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): We propose to develop an inexpensive high-throughput means of selecting and identifying antibodies to both unmodified and modified protein, peptide, and non-peptide antigens. The specific goals of this proposal are to complete a proof-of-concept using aqueous droplets in an oil emulsion for identification and isolation of scFv antibodies. Compartmentalization ...

    SBIR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  3. TSF Supervisor's Toolkit

    SBC: CBT4CBT LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Our recent series of innovative randomized trials evaluating the efficacy of various strategies for training clinicians to use evidence based therapies in alcohol and drug abuse has indicated that while both in-person workshop and computer-assisted training can impart the skills necessary to deliver Twelve Step Facilitation, they are by no means sufficient in e ...

    SBIR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  4. Polypeptide Multilayer Nanofilms for Synthetic Biomatrix Development

    SBC: ARTIFICIAL CELL TECHNOLOGIES INC            Topic: N/A

    DESCRIPTION (provided by applicant): This SBIR Phase I project will determine the feasibility of applying polypeptide multilayer nanofilm technology to synthetic biomatrix development and commercialization. These nanofilms are a type of surface coating for cell and tissue culture. Immediate in vitro uses of synthetic biomatrix materials include many areas of basic medical research, diagnostic test ...

    SBIR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  5. Public Rights-of-Way Assessment Instrumentation to Determine Accessibility

    SBC: BENEFICIAL DESIGNS INC            Topic: N/A

    Cities must perform detailed assessments of sidewalks and streets, including curb ramps, pedestrian signals, crosswalks, street furniture, and other components to determine compliance with the Public Rights-of-Way Accessibility Guidelines. However, current assessment methods are inadequate or unreasonable due to time and resources required. The objectives of this project are to: 1) develop elect ...

    SBIR Phase I 2008 Department of Transportation
  6. Multimodal Diagnostic and Therapeutic Nanoparticles for Non-Hodgkin's Lymphoma

    SBC: Carigent Therapeutics            Topic: N/A

    DESCRIPTION (provided by applicant): The long-term clinical objective of this proposal Multimodal Diagnostic and Therapeutic Nanoparticles for Non-Hodgkin's Lymphoma is the development of a novel therapeutic and diagnostic drug delivery technology for sp ecific use in the treatment of non-Hodgkin's lymphoma. The combination of non-invasive imaging techniques such as MRI and targeted drug deliver ...

    SBIR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health
  7. A Platform for Standardized Comparisons of Repair Protocols for the Craniofacial

    SBC: CyberConnect EZ, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Tissue engineering currently has little discipline in assessing the efficacy of biomaterials through in vivo experiments. This lack of discipline poses a serious challenge to the community as it will soon be inundated with scaffold biomaterials and alternative progenitor and stem cells. The community needs to establish a systematic way of evaluating which combi ...

    SBIR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  8. Developing Contractual Service Framework for Bone Histomorphometry

    SBC: CyberConnect EZ, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): This project aims at developing software technology capable of automating bone histomorphometry, which at the moment is mostly done manually through cumbersome and laborious interactive processes. Our plan is to use state-of-the-art image processing techniques to automate detection, measurement and quantification of biological effects directly over the stained ...

    SBIR Phase I 2009 Department of Health and Human ServicesNational Institutes of Health
  9. Novel Transgenic Rabbit Model for Cardiovascular Disease

    SBC: EVERGEN BIOTECHNOLOGIES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Cardiovascular disease (CVD) is the single most common cause of death in the United States. Although the study of the CVD has greatly benefited from the use of gene-targeted transgenic mouse models, these small rodents do not accurately reflect human cardiovascular physiology. The Rabbit would be an excellent animal model for CVD research, considering its many ...

    SBIR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health
  10. DNA Diagnostic System for Statin Safety and Efficacy

    SBC: GENOMAS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Statins are the most prescribed drugs in the world. Their efficacy in primary and secondary prevention of cardiovascular disease as well as beneficial pleiotrophic and anti-inflammatory effects have fostered increasingl y aggressive usage and dosage. Their main clinically relevant safety risk is statin-induced myopathy (SIM) evidenced clinically as a constellat ...

    SBIR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government